Compile Data Set for Download or QSAR

Found 23 hits Enz. Inhib. hit(s) with all data for assayid = 4 entry = 50006658   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052125 (3-((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5,10,10b-Trihy...) Show SMILES CCOC(=O)CCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C26H41NO9/c1-8-23(5)14-16(29)26(33)24(6)15(28)10-12-22(3,4)19(24)18(20(31)25(26,7)36-23)35-21(32)27-13-11-17(30)34-9-2/h8,15,18-20,28,31,33H,1,9-14H2,2-7H3,(H,27,32)/t15-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052111 ((2-Methoxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...) Show SMILES COCCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C24H39NO8/c1-8-21(4)13-15(27)24(30)22(5)14(26)9-10-20(2,3)17(22)16(18(28)23(24,6)33-21)32-19(29)25-11-12-31-7/h8,14,16-18,26,28,30H,1,9-13H2,2-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052144 ((2-Hydroxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCO)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C23H37NO8/c1-7-20(4)12-14(27)23(30)21(5)13(26)8-9-19(2,3)16(21)15(17(28)22(23,6)32-20)31-18(29)24-10-11-25/h7,13,15-17,25-26,28,30H,1,8-12H2,2-6H3,(H,24,29)/t13-,15-,16-,17-,20-,21-,22+,23-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052134 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-(3,...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCC(C)(C)C)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C29H47NO8/c1-11-26(8)16-19(33)29(35)27(9)18(32)12-13-25(6,7)21(27)20(22(36-17(2)31)28(29,10)38-26)37-23(34)30-15-14-24(3,4)5/h11,18,20-22,32,35H,1,12-16H2,2-10H3,(H,30,34)/t18-,20-,21-,22-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052113 ((2-Methoxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...) Show SMILES COCCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C24H39NO8/c1-8-21(4)13-15(27)24(30)22(5)14(26)9-10-20(2,3)17(22)16(28)18(23(24,6)33-21)32-19(29)25-11-12-31-7/h8,14,16-18,26,28,30H,1,9-13H2,2-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052120 (CHEMBL419139 | Isobutyl-carbamic acid (3R,4aR,5S,6...) Show SMILES CC(C)CNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C25H41NO7/c1-9-22(6)12-16(28)25(31)23(7)15(27)10-11-21(4,5)18(23)17(19(29)24(25,8)33-22)32-20(30)26-13-14(2)3/h9,14-15,17-19,27,29,31H,1,10-13H2,2-8H3,(H,26,30)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052115 ((2-Dimethylamino-ethyl)-carbamic acid (3R,4aR,5S,6...) Show SMILES CN(C)CCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C25H42N2O7/c1-9-22(4)14-16(29)25(32)23(5)15(28)10-11-21(2,3)18(23)17(30)19(24(25,6)34-22)33-20(31)26-12-13-27(7)8/h9,15,17-19,28,30,32H,1,10-14H2,2-8H3,(H,26,31)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052139 (Allyl-carbamic acid (3R,4aR,5S,6S,6aS,10S,10aR,10b...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCC=C)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C24H37NO7/c1-8-12-25-19(29)31-16-17-20(3,4)11-10-14(26)22(17,6)24(30)15(27)13-21(5,9-2)32-23(24,7)18(16)28/h8-9,14,16-18,26,28,30H,1-2,10-13H2,3-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052122 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES CC(C)CNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C27H43NO8/c1-10-24(7)13-18(31)27(33)25(8)17(30)11-12-23(5,6)20(25)19(35-22(32)28-14-15(2)3)21(34-16(4)29)26(27,9)36-24/h10,15,17,19-21,30,33H,1,11-14H2,2-9H3,(H,28,32)/t17-,19-,20-,21-,24-,25-,26+,27-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052121 (3-((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-Trihy...) Show SMILES CCOC(=O)CCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C26H41NO9/c1-8-23(5)14-16(29)26(33)24(6)15(28)10-12-22(3,4)19(24)18(31)20(25(26,7)36-23)35-21(32)27-13-11-17(30)34-9-2/h8,15,18-20,28,31,33H,1,9-14H2,2-7H3,(H,27,32)/t15-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052145 (CHEMBL93252 | [2-(4-Amino-phenyl)-ethyl]-carbamic ...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCc1ccc(N)cc1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H42N2O7/c1-7-26(4)16-20(33)29(36)27(5)19(32)12-14-25(2,3)22(27)21(23(34)28(29,6)38-26)37-24(35)31-15-13-17-8-10-18(30)11-9-17/h7-11,19,21-23,32,34,36H,1,12-16,30H2,2-6H3,(H,31,35)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052133 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-cyc...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCC2CCCCC2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C30H47NO8/c1-8-27(5)16-21(34)30(36)28(6)20(33)14-15-26(3,4)23(28)22(24(37-18(2)32)29(30,7)39-27)38-25(35)31-17-19-12-10-9-11-13-19/h8,19-20,22-24,33,36H,1,9-17H2,2-7H3,(H,31,35)/t20-,22-,23-,24-,27-,28-,29+,30-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052149 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-all...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCC=C)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C26H39NO8/c1-9-13-27-21(31)34-18-19-22(4,5)12-11-16(29)24(19,7)26(32)17(30)14-23(6,10-2)35-25(26,8)20(18)33-15(3)28/h9-10,16,18-20,29,32H,1-2,11-14H2,3-8H3,(H,27,31)/t16-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052138 (Allyl-carbamic acid (3R,4aR,5S,6S,6aS,10S,10aR,10b...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCC=C)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C24H37NO7/c1-8-12-25-19(29)31-18-16(28)17-20(3,4)11-10-14(26)22(17,6)24(30)15(27)13-21(5,9-2)32-23(18,24)7/h8-9,14,16-18,26,28,30H,1-2,10-13H2,3-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052114 (CHEMBL93468 | Phenethyl-carbamic acid (3R,4aR,5S,6...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccccc1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H41NO7/c1-7-26(4)17-20(32)29(35)27(5)19(31)13-15-25(2,3)22(27)21(33)23(28(29,6)37-26)36-24(34)30-16-14-18-11-9-8-10-12-18/h7-12,19,21-23,31,33,35H,1,13-17H2,2-6H3,(H,30,34)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052135 ((2-Dimethylamino-ethyl)-carbamic acid (3R,4aR,5S,6...) Show SMILES CN(C)CCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C25H42N2O7/c1-9-22(4)14-16(29)25(32)23(5)15(28)10-11-21(2,3)18(23)17(19(30)24(25,6)34-22)33-20(31)26-12-13-27(7)8/h9,15,17-19,28,30,32H,1,10-14H2,2-8H3,(H,26,31)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052128 (CHEMBL92687 | Cyclohexylmethyl-carbamic acid (3R,4...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCC1CCCCC1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C28H45NO7/c1-7-25(4)15-19(31)28(34)26(5)18(30)13-14-24(2,3)21(26)20(32)22(27(28,6)36-25)35-23(33)29-16-17-11-9-8-10-12-17/h7,17-18,20-22,30,32,34H,1,8-16H2,2-6H3,(H,29,33)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052118 (CHEMBL330704 | Propyl-carbamic acid (3R,4aR,5S,6S,...) Show SMILES CCCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C24H39NO7/c1-8-12-25-19(29)31-16-17-20(3,4)11-10-14(26)22(17,6)24(30)15(27)13-21(5,9-2)32-23(24,7)18(16)28/h9,14,16-18,26,28,30H,2,8,10-13H2,1,3-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052116 (CHEMBL93260 | Isobutyl-carbamic acid (3R,4aR,5S,6S...) Show SMILES CC(C)CNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C25H41NO7/c1-9-22(6)12-16(28)25(31)23(7)15(27)10-11-21(4,5)18(23)17(29)19(24(25,8)33-22)32-20(30)26-13-14(2)3/h9,14-15,17-19,27,29,31H,1,10-13H2,2-8H3,(H,26,30)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052119 ((3,3-Dimethyl-butyl)-carbamic acid (3R,4aR,5S,6S,6...) Show SMILES CC(C)(C)CCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C27H45NO7/c1-10-24(7)15-17(30)27(33)25(8)16(29)11-12-23(5,6)19(25)18(20(31)26(27,9)35-24)34-21(32)28-14-13-22(2,3)4/h10,16,18-20,29,31,33H,1,11-15H2,2-9H3,(H,28,32)/t16-,18-,19-,20-,24-,25-,26+,27-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052136 (3-((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-Acetoxy-10,1...) Show SMILES CCOC(=O)CCNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C28H43NO10/c1-9-25(6)15-18(32)28(35)26(7)17(31)11-13-24(4,5)21(26)20(22(37-16(3)30)27(28,8)39-25)38-23(34)29-14-12-19(33)36-10-2/h9,17,20-22,31,35H,1,10-15H2,2-8H3,(H,29,34)/t17-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052112 ((3,3-Dimethyl-butyl)-carbamic acid (3R,4aR,5S,6S,6...) Show SMILES CC(C)(C)CCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C27H45NO7/c1-10-24(7)15-17(30)27(33)25(8)16(29)11-12-23(5,6)19(25)18(31)20(26(27,9)35-24)34-21(32)28-14-13-22(2,3)4/h10,16,18-20,29,31,33H,1,11-15H2,2-9H3,(H,28,32)/t16-,18-,19-,20-,24-,25-,26+,27-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052127 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES CCCNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C26H41NO8/c1-9-13-27-21(31)34-18-19-22(4,5)12-11-16(29)24(19,7)26(32)17(30)14-23(6,10-2)35-25(26,8)20(18)33-15(3)28/h10,16,18-20,29,32H,2,9,11-14H2,1,3-8H3,(H,27,31)/t16-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair